Notably, further studies using tamoxifen-regulatable promotors specific for hepatocytes or cholangiocytes revealed that in the described mutant KRAS/Pten mice, CCA originates from biliary cells [67,68]. This evidence concerns the gene KRAS and cholangiocarcinoma.